SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,389,000 | -35.5% | 92,721 | -47.6% | 0.26% | -17.7% |
| Q1 2016 | $2,154,000 | -8.1% | 177,003 | +20.2% | 0.31% | +23.0% |
| Q4 2015 | $2,343,000 | +7.9% | 147,265 | +4.0% | 0.25% | +20.6% |
| Q3 2015 | $2,171,000 | -39.1% | 141,629 | -3.4% | 0.21% | -39.9% |
| Q2 2015 | $3,565,000 | +102.3% | 146,646 | +93.5% | 0.35% | +101.2% |
| Q1 2015 | $1,762,000 | -43.5% | 75,782 | -38.9% | 0.17% | -41.8% |
| Q4 2014 | $3,116,000 | -28.7% | 124,076 | -11.7% | 0.30% | -21.6% |
| Q3 2014 | $4,370,000 | +492.1% | 140,527 | +392.5% | 0.38% | +553.4% |
| Q2 2014 | $738,000 | +70.4% | 28,531 | +53.9% | 0.06% | +100.0% |
| Q1 2014 | $433,000 | -19.1% | 18,534 | -12.1% | 0.03% | +16.0% |
| Q4 2013 | $535,000 | -82.4% | 21,078 | -85.8% | 0.02% | -81.9% |
| Q3 2013 | $3,033,000 | +132.2% | 148,657 | +138.7% | 0.14% | +150.9% |
| Q2 2013 | $1,306,000 | – | 62,265 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 462,824 | $7,364,000 | 8.63% |
| HealthCor Management, L.P. | 1,750,000 | $27,843,000 | 1.69% |
| ACUTA CAPITAL PARTNERS, LLC | 144,667 | $2,302,000 | 1.10% |
| THB ASSET MANAGEMENT | 615,546 | $9,793,000 | 1.05% |
| Penn Capital Management Company, LLC | 1,399,205 | $22,261,000 | 0.98% |
| Tamarack Advisers, LP | 450,000 | $7,160,000 | 0.94% |
| Piermont Capital Management Inc. | 139,020 | $2,212,000 | 0.70% |
| JW Asset Management, LLC | 101,630 | $1,617,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 810,362 | $12,893,000 | 0.55% |
| Glacier Peak Capital LLC | 50,000 | $796,000 | 0.51% |